Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atricure (ATRC)
NASDAQ:ATRC
Holding ATRC?
Track your performance easily
ATRC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$18.94 - $43.00
Previous Close$38.2
Volume48.39K
Average Volume (3M)590.25K
Market Cap
$1.82B
Enterprise Value$1.79B
Total Cash (Recent Filing)$130.34M
Total Debt (Recent Filing)$61.87M
Price to Earnings (P/E)―
Beta1.59
Next Earnings
Feb 25, 2025EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.83
Shares Outstanding48,753,251
10 Day Avg. Volume922,688
30 Day Avg. Volume590,247
Standard Deviation0.13
R-Squared0.34
Alpha-0.00530
Financial Highlights & Ratios
Price to Book (P/B)4.00
Price to Sales (P/S)4.08
Price to Cash Flow (P/CF)22.80
P/FCF Ratio27.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.01
Enterprise Value/Gross Profit5.97
Enterprise Value/Ebitda-115.36
Forecast
1Y Price Target
$44.75Price Target Upside20.07% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Atricure News
PremiumCompany Announcements
AtriCure Reports Strong Growth in Q3 2024 Earnings
Bulls Say, Bears Say
Bulls Say
Financial PerformanceManagement raised full-year sales guidance, indicating confidence in future performance.
New Product LaunchesSeveral new product launches are slated for the second half of the year, highlighting growth opportunities.
Partnership And InnovationATRC entered into an exclusive license agreement to add PFA to their portfolio, suggesting potential for future growth.
Bears Say
Financial PerformanceATRC's gross, operating, and adjusted EBITDA margins were down 170 basis points, 210 basis points, and 120 basis points year-over-year, respectively, with the gross margin decline driven by geographic and product mix.
Market DynamicsThe negative impacts to the business stemmed from Electrophysiologists shifting their time to new Pulse Field Ablation catheter devices.
Revenue GuidanceThe company lowered full-year 2024 guidance by approximately $4 million due to the relative softness within its MIS Ablation and MIS Appendage Management segments.
---
Ownership Overview
3.17% Insiders
36.49% Mutual Funds
6.60% Other Institutional Investors
37.93% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ATRC FAQ
What was Atricure’s price range in the past 12 months?
Atricure lowest stock price was $18.94 and its highest was $43.00 in the past 12 months.
What is Atricure’s market cap?
Currently, no data Available
When is Atricure’s upcoming earnings report date?
Atricure’s upcoming earnings report date is Feb 25, 2025 which is in 104 days.
How were Atricure’s earnings last quarter?
Atricure released its earnings results on Oct 29, 2024. The company reported -$0.17 earnings per share for the quarter, beating the consensus estimate of -$0.195 by $0.025.
Is Atricure overvalued?
According to Wall Street analysts Atricure’s price is currently Undervalued.
Does Atricure pay dividends?
Atricure does not currently pay dividends.
What is Atricure’s EPS estimate?
Atricure’s EPS estimate is -$0.23.
How many shares outstanding does Atricure have?
Atricure has 48,753,250 shares outstanding.
What happened to Atricure’s price movement after its last earnings report?
Atricure reported an EPS of -$0.17 in its last earnings report, beating expectations of -$0.195. Following the earnings report the stock price went up 18.349%.
Which hedge fund is a major shareholder of Atricure?
Among the largest hedge funds holding Atricure’s share is Royce & Associates LLC. It holds Atricure’s shares valued at 1M.
---
Atricure Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$44.75 (20.07% Upside)
$44.75 (20.07% Upside)
Blogger Sentiment
Bullish
ATRC Sentiment 100%
Sector Average 73%
Sector Average 73%
Hedge Fund Trend
Decreased
By 110.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $84.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 7.4%
Last 30 Days ▼ 7.4%
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.92%
12-Months-Change
Fundamentals
Return on Equity
-8.39%
Trailing 12-Months
Asset Growth
2.46%
Trailing 12-Months
Company Description
Atricure
AtriCure, Inc. engages development, manufacture and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio Frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, Other International, and Total International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.
---
ATRC Company Deck
---
ATRC Earnings Call
Q3 2024
0:00 / 0:00
---
ATRC Stock 12 Month Forecast
Average Price Target
$44.75
▲(20.07% Upside)
Technical Analysis
Best Analysts Covering ATRC
1 Year
1 Year Success Rate
20/22 ratings generated profit
1 Year Average Return
+47.83%
reiterated a buy rating 14 days ago
Copying Suraj Kalia's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +47.83% per trade.
---